Quince Therapeutics
QNCX
#9115
Rank
โ‚น6.65 B
Marketcap
โ‚น151.34
Share price
1.14%
Change (1 day)
61.03%
Change (1 year)

EPS for Quince Therapeutics (QNCX)

EPS in 2023 (TTM): -โ‚น68.09

According to Quince Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น70.57. In 2022 the company made an earnings per share (EPS) of -โ‚น134.34 an increase over its 2021 EPS that were of -โ‚น257.62.

EPS history for Quince Therapeutics from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น68.09-49.32%
2022-โ‚น134.34-47.85%
2021-โ‚น257.6215.21%
2020-โ‚น223.6162.51%
2019-โ‚น137.60179.56%
2018-โ‚น49.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น185.35 162.65%๐Ÿ‡บ๐Ÿ‡ธ USA